The Scientific Board is one of the vital bodies of EU-IPFF.
The role of the Scientific Board includes:

Review publications
and documents

Support advocacy initiatives targeting the EU institutions

Help foster dialogue with medical societies, regulators and payers

Support publication in medical and specialised press

Scientific Advisory Board Members


Dr. Helmut Prosch
Medical University
Vienna

Prof. Benoit Wallaert
 
Hospital Albert Calmette
Lille

Prof. Wim Wuyts
University Hospital
Leuven

Dr. Francesco Bonella Ruhrlandklinik Medical Faculty
 University of Duisburg-Essen

Dr. Benjamin Bondue
Erasme Hospital
Université Libre de Bruxelles

Prof. Andreas Günther
University Hospital Giessen

003-france.png

Prof. Vincent Cottin
CHU
Lyon

Dr. Katherine O'Reilly
Mater Misericordiae University Hospital, Dublin

Dr. Elisabetta Balestro
Azienda Ospedaliera di Padova,
Università degli Studi di Padova

007-spain.png

Dr. Maria Molina
Health Universitat de
Barcelona Campus

Prof. Demosthenes Bouros
National and Kapodistrian University of Athens

Dr. Stefania Cerri
 University of Modena
and Reggio Emilia

Dr. Claudia Valenzuela
Hospital La Princesa  
Comunidad de Madrid

Prof. Luca Richeldi
University of
Southampton

Dr. Helen Parfrey
Papworth Hospital

Dr. Marlies Wijsenbeek
Erasmus Medisch Centrum Rotterdam

download (3).png

Anne-Marie Russell
Imperial College London

 
 

Some of the members of the Scientific Advisory Board took part in the establishment of the European IPF Charter and provided valuable insights into the medical background of some of the problems that IPF patients face. In addition, they were able to publish an extensive article about the creation of the IPF Charter in Europe’s most renowned scientific journal focused on lung diseases; The European Respiratory Journal. To view the abstract or download the article, please visit the ERS website

 
 

The European Reference Network (ERN) aims to connect highly specialised healthcare professionals across EU Member States and to thereby improve access to diagnosis, treatment and provision of high quality healthcare for patients with rare diseases or conditions that require a concentration of resources, expertise and knowledge. The EU-IPFF Scientific Advisory Board has submitted the application for an ERN on Rare Pulmonary Diseases (ERN Lung) including a sub-network on Interstitial Lung Diseases (ILDs) including IPF. The aim is to ensure that IPF diagnosis, care and treatment options is unified across Europe and that patients are able to live their lives to the fullest.

Relevant professional networks and organisations

 
Interdisciplinary ILD Network  

Interdisciplinary ILD Network